SGMT
Sagimet Biosciences
$10.74
+$0.32 (+3.07%)Oct 28, 2026
Key metrics
The numbers that frame SGMT today
- Market cap
- $667.58M
- ROIC
- -58.3%
- Div yield
- 0%
- Debt / equity
- 0.0
- 52wk Low
- $4.50
- 52wk High
- $11.45
Growth
Revenue and earnings trend for SGMT
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about SGMT
Is Sagimet Biosciences a good buy?
Hold. Sagimet Biosciences has excellent momentum, but poor quality makes the setup mixed. Growth looks poor. That could put pressure on the long-term business case. We think Sagimet Biosciences is selling at a very high price.
What is the market capitalization of SGMT?
Sagimet Biosciences's market capitalization is $667.58M.
What is the 52-week high for SGMT stock?
The 52-week high for Sagimet Biosciences is $11.45. The current close of $10.74 is 6.2% below that high.
What is the 52-week low for SGMT stock?
The 52-week low for Sagimet Biosciences is $4.50. The current close of $10.74 is 138.7% above that low.
Does SGMT stock pay dividends?
Sagimet Biosciences does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for SGMT?
Sagimet Biosciences's Debt / Equity ratio is 0.01.